Business Description
Nexalin Technology Inc
NAICS : 423450
SIC : 5047
ISIN : US65345B2016
Total Employee Number:
8Description
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -36.77 | |||||
Beneish M-Score | -5.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -57.7 | |||||
3-Year EBITDA Growth Rate | -15.8 | |||||
3-Year EPS without NRI Growth Rate | -18.7 | |||||
3-Year FCF Growth Rate | 8.2 | |||||
3-Year Book Growth Rate | -36.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.3 | |||||
9-Day RSI | 42.98 | |||||
14-Day RSI | 43.1 | |||||
3-1 Month Momentum % | 56.29 | |||||
6-1 Month Momentum % | -5.6 | |||||
12-1 Month Momentum % | -43.88 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.07 | |||||
Quick Ratio | 3.85 | |||||
Cash Ratio | 3.35 | |||||
Days Inventory | 1194.28 | |||||
Days Sales Outstanding | 53.96 | |||||
Days Payable | 1302.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -38.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.88 | |||||
Operating Margin % | -3079.71 | |||||
Net Margin % | -3018.48 | |||||
EBITDA Margin % | -3069.57 | |||||
FCF Margin % | -1955.07 | |||||
OCF Margin % | -1900 | |||||
ROE % | -211.55 | |||||
ROA % | -181.74 | |||||
ROIC % | -1265.63 | |||||
3-Year ROIIC % | -9936.36 | |||||
ROC (Joel Greenblatt) % | -11258.28 | |||||
ROCE % | -215.83 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 22.56 | |||||
PB Ratio | 2.58 | |||||
Price-to-Tangible-Book | 3.01 | |||||
EV-to-EBIT | -0.6 | |||||
EV-to-EBITDA | -0.6 | |||||
EV-to-Revenue | 18.36 | |||||
EV-to-FCF | -0.94 | |||||
Price-to-GF-Value | 0.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.01 | |||||
| Price-to-Net-Cash | 4.01 | |||||
Earnings Yield (Greenblatt) % | -166.67 | |||||
FCF Yield % | -69.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NXL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nexalin Technology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.276 | ||
| EPS (TTM) ($) | -0.47 | ||
| Beta | 2.331 | ||
| 3-Year Sharpe Ratio | 0.59 | ||
| 3-Year Sortino Ratio | 2.29 | ||
| Volatility % | 128 | ||
| 14-Day RSI | 43.1 | ||
| 14-Day ATR ($) | 0.045404 | ||
| 20-Day SMA ($) | 0.405645 | ||
| 12-1 Month Momentum % | -43.88 | ||
| 52-Week Range ($) | 0.305 - 2 | ||
| Shares Outstanding (Mil) | 21.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nexalin Technology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nexalin Technology Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 132 days | ||
| Second quarter earnings results for 2026 | 2026-08-06 | In 33 days | ||
| General meeting for 2026 | 2026-07-15 10:00 | In 12 days | ||
| First quarter earnings results for 2026 | 2026-05-08 | 0.34 (-6.78%) | ||
| Annual report for 2025 | 2026-03-25 | 0.41 (-1.43%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 1.17 (-7.14%) | ||
| Second quarter earnings results for 2025 | 2025-08-06 | 1.02 (+0.00%) | ||
| General meeting for 2025 | 2025-07-15 10:00 | 1.03 (+3.00%) | ||
| First quarter earnings results for 2025 | 2025-05-13 | 1.25 (-3.85%) | ||
| Annual report for 2024 | 2025-03-14 | 1.95 (-12.95%) |
Show
Entries
Nexalin Technology Inc Frequently Asked Questions
What is Nexalin Technology Inc(NXL)'s stock price today?
The current price of NXL is $0.36. The 52 week high of NXL is $2.00 and 52 week low is $0.31.
When is next earnings date of Nexalin Technology Inc(NXL)?
The next earnings date of Nexalin Technology Inc(NXL) is 2026-08-06 Est..
Does Nexalin Technology Inc(NXL) pay dividends? If so, how much?
Nexalin Technology Inc(NXL) does not pay dividend.
Guru Commentaries on NAS:NXL
No articles.
Press Release
Articles on Nexalin Technology Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers